Literature DB >> 1298991

Increase in spontaneous platelet aggregation in beta-thalassemia/hemoglobin E disease: a consequence of splenectomy.

N Opartkiattikul1, Y Funahara, S Fucharoen, P Talalak.   

Abstract

Clinical symptoms related with disturbances of the circulatory system are often observed in beta-thalassemia/hemoglobin E (beta-thal/HbE) patients after splenectomy. Pulmonary thrombosis is one of the important contributing factors. However, the pathogenesis of this phenomenon was not known. Previous studies on platelet functions were controversial as platelet-rich plasma (PRP) was employed for all of the studies. By centrifugation, most of the hyperactive platelets were excluded before platelet aggregation tests were performed. Besides, the role of red cells related to platelet aggregation was not investigated. In this study, a platelet function test was designed to avoid these two handicaps of previous work as mentioned, by using whole blood from 15 normal and 40 beta-thal/HbE patients (15 nonsplenectomized and 25 splenectomized) to study spontaneous platelet aggregation. The principle of the test was to evaluate platelet number in whole blood by electronic platelet counter at time 0 (45 minutes after blood collection) and this number was used as 100% of free unaggregated platelets. Then the same specimen of whole blood was incubated at 37 degrees C with continuous stirring by magnetic stirrer in an aggregometer for 8 minutes; at 1 minute intervals free unaggregated platelets were evaluated and calculated as a percentage of the initial control value. The results indicated increased spontaneous platelet aggregation in whole blood of post-splenectomized beta-thal/HbE patients. The residual free platelet number were 24% at 8 minutes after incubation. Effects of red blood cells on spontaneous platelet aggregation were studied by mixing autologous beta-thal/HbE red cells obtained from splenectomized and non-splenectomized patients with platelet rich plasma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1298991

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  5 in total

1.  Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia.

Authors:  A Phrommintikul; A Sukonthasarn; R Kanjanavanit; W Nawarawong
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

2.  In vivo platelet activation and hyperaggregation in hemoglobin E/beta-thalassemia: a consequence of splenectomy.

Authors:  Vichai Atichartakarn; Pantep Angchaisuksiri; Katcharin Aryurachai; Suporn Chuncharunee; Ammarin Thakkinstian
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

Review 3.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

4.  Effect of acetylsalicylic acid on thalassemia with pulmonary arterial hypertension.

Authors:  Nonlawan Chueamuangphan; Wattana Wongtheptian; Jayanton Patumanond; Apichard Sukonthasarn; Suporn Chuncharunee; Chamaiporn Tawichasri; Weerasak Nawarawong
Journal:  Int J Gen Med       Date:  2014-12-03

5.  Benefits of chronic blood transfusion in hemoglobin E/β thalassemia with pulmonary arterial hypertension.

Authors:  Nonlawan Chueamuangphan; Jayanton Patumanond; Wattana Wongtheptien; Weerasak Nawarawong; Apichard Sukonthasarn; Suporn Chuncharunee; Chamaiporn Tawichasri
Journal:  Int J Gen Med       Date:  2014-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.